The Obama Administration often proclaims that it works overtime to strengthen the competitive position of U.S. industry. If it's sincere about this claim, it should be working to lower the time and cost that it takes pharmaceutical companies to bring new medicines to market, estimated to be over a decade at a cost of $1.3 billion per drug.